Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Peptide to glycopeptide: glycosylated oligopeptide renin inhibitors with attenuated in vivo clearance properties.

× No keyword cloud information.

13 in total

Review 1. CNS drug delivery: opioid peptides and the blood-brain barrier.

Authors: Ken A Witt; Thomas P Davis
Journal: AAPS J Date: 2006-02-24 Impact factor: 4.009

2. Design of a functionally equivalent nonglycosylated analog of the glycopeptide antibiotic formaecin I.

Authors: Kanwal J Kaur; Shashank Pandey; Dinakar M Salunke
Journal: Protein Sci Date: 2007-02 Impact factor: 6.725

3. Glucose conjugation for the specific targeting and treatment of cancer.

Authors: Emilia C Calvaresi; Paul J Hergenrother
Journal: Chem Sci Date: 2013-06 Impact factor: 9.825

4. Glycans Meet Sphingolipids: Structure-Based Design of Glycan Containing Analogues of a Sphingosine Kinase Inhibitor.

Authors: Athanasios Papakyriakou; Francesca Cencetti; Elisa Puliti; Laura Morelli; Jacopo Tricomi; Paola Bruni; Federica Compostella; Barbara Richichi
Journal: ACS Med Chem Lett Date: 2020-03-30 Impact factor: 4.345

5. Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier.

Authors: R Polt; F Porreca; L Z Szabò; E J Bilsky; P Davis; T J Abbruscato; T P Davis; R Harvath; H I Yamamura; V J Hruby
Journal: Proc Natl Acad Sci U S A Date: 1994-07-19 Impact factor: 11.205

6. Peptide stability in drug development. II. Effect of single amino acid substitution and glycosylation on peptide reactivity in human serum.

Authors: M F Powell; T Stewart; L Otvos; L Urge; F C Gaeta; A Sette; T Arrhenius; D Thomson; K Soda; S M Colon
Journal: Pharm Res Date: 1993-09 Impact factor: 4.200

Peptide to glycopeptide: glycosylated oligopeptide renin inhibitors with attenuated in vivo clearance properties.

Review 1. CNS drug delivery: opioid peptides and the blood-brain barrier.

2. Design of a functionally equivalent nonglycosylated analog of the glycopeptide antibiotic formaecin I.

3. Glucose conjugation for the specific targeting and treatment of cancer.

4. Glycans Meet Sphingolipids: Structure-Based Design of Glycan Containing Analogues of a Sphingosine Kinase Inhibitor.

5. Glycopeptide enkephalin analogues produce analgesia in mice: evidence for penetration of the blood-brain barrier.

6. Peptide stability in drug development. II. Effect of single amino acid substitution and glycosylation on peptide reactivity in human serum.

7. D-19575--a sugar-linked isophosphoramide mustard derivative exploiting transmembrane glucose transport.

8. Effect of carbohydrate structure on biological activity of artificially N-glycosylated eel calcitonin.

Review 9. The clinical potential of renin inhibitors and angiotensin antagonists.

10. Can amphipathic helices influence the CNS antinociceptive activity of glycopeptides related to β-endorphin?